Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
Authors
Keywords
-
Journal
Nature Microbiology
Volume 5, Issue 11, Pages 1439-1448
Publisher
Springer Science and Business Media LLC
Online
2020-10-07
DOI
10.1038/s41564-020-00802-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Connecting With Patients—The Missing Links
- (2020) Lisa Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
- (2020) Lu Lin et al. GUT
- Drug repositioning is an alternative for the treatment of coronavirus COVID-19
- (2020) Marissa B. Serafin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
- (2020) Vincent J. Munster et al. NATURE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
- (2020) Muhammad Usman Mirza et al. Journal of Pharmaceutical Analysis
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Bismuth Porphyrin Antagonizes Cisplatin-Induced Nephrotoxicity via Unexpected Metallothionein-Independent Mechanisms
- (2020) Runming Wang et al. iScience
- Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis
- (2019) Zhihui Jia et al. NUCLEIC ACIDS RESEARCH
- Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
- (2018) Runming Wang et al. Nature Communications
- The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy
- (2018) Jasper Fuk-Woo Chan et al. ANTIVIRAL RESEARCH
- A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication
- (2016) Shuofeng Yuan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Cross-Protection of Influenza A Virus Infection by a DNA Aptamer Targeting the PA Endonuclease Domain
- (2015) Shuofeng Yuan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
- (2015) Jasper F. W. Chan et al. CLINICAL MICROBIOLOGY REVIEWS
- Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase
- (2012) Adeyemi O. Adedeji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target
- (2012) Young-Sam Keum et al. BIOCHEMICAL PHARMACOLOGY
- Recent advances in bioinorganic chemistry of bismuth
- (2012) Hongyan Li et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
- (2010) S. Cun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More